Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
EDITORIAL
Year : 2016  |  Volume : 12  |  Issue : 4  |  Page : 1215

One last time


Department of Radiation Oncology, Nanavati Super Speciality Hospital, Mumbai, Maharashtra, India

Date of Web Publication7-Feb-2017

Correspondence Address:
Nagraj Huilgol
Nanavati Hospital, ACRO, Basement Level, S. V. Road, Vile Parle West, Mumbai - 400 056, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.199543

Rights and Permissions

How to cite this article:
Huilgol N. One last time. J Can Res Ther 2016;12:1215

How to cite this URL:
Huilgol N. One last time. J Can Res Ther [serial online] 2016 [cited 2017 Jul 26];12:1215. Available from: http://www.cancerjournal.net/text.asp?2016/12/4/1215/199543

Journal of Cancer Research and Therapeutics (JCRT) was started in early 2005. It was to be a platform for oncologists from India and Asia-Pacific. Science knows no boundaries. Articles from across the world poured in. The reach of JCRT became global. The journal soon got pub indexed. Citation index reached more than one. It was listed as one of the ten journals in the area of medicine (current science).

Now, it is the time for the journal which needs to create more impact on the world stage. If could start with China and Asia-Pacific, I wish to acknowledge few people in person though the credit for the success story goes to every member of the editorial board, contributors, and reviewers. Dr. Rajiv Sarin, Dr. Shyam Srivastava, Dr. Rajesh Vaishistha, Dr. Rakesh Jalali, and Chaitra Jaidev.

Journals have proliferated exponentially over the past 10–15 years. Digital journals have ensured a worldwide reach at an affordable cost. The responsibility of peer reviewers and editors, thus, is more than ever peer review has remained an honorary job. It is a herculean task for any fledgling journal to get the best referees who will review in time. The delays in turnaround time troubled us. The financial remuneration for referees was discussed with core group and the lead referees: it was felt not very prudent to lure reviewers with financial incentives. The ever-proliferating journals of all have put a pressure on this rare species, “reviewers.” The scientific community collectively needs to deliberate on the issue of financial remuneration to referees. Plagiarism is an emerging concern for editors. The artificial intelligence-based plagiarism checks sometimes are not good enough to spot even a blatant plagiarism of ideas and data. This requires ever-vigilant referees. JCRT has had its share of this problem. Those who Plagiarized were penalized. Publishing any journal is a gargantuan exercise. It is a co-ordinated effort. JCRT has done splendidly so far.

It is now evident that important research performed and published in journals in language other than English goes unnoticed. It is indeed a colossal loss of information to the scientific community. Similarly, significant literature in English goes unnoticed in non-English-speaking countries. That is why JCRT has extended its reach to China. Abstracts are translated into Chinese to enhance and promote the ease of access of articles published in JCRT to a larger non-English-speaking audience.

JCRT is on its way to be global. I thank everyone making JCRT what it is today. A new editor, new thought, and new style will be evident with the new editor and his team. One last time, I say thank you all.




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article

 Article Access Statistics
    Viewed588    
    Printed16    
    Emailed0    
    PDF Downloaded80    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]